Video Content

18th Oct 17

Pharmaxis Business Model

Pharmaxis CEO Gary Phillips discusses the Company’s approach to commercialising its drug discoveries. (Watch the video here)

8th Sep 17

New Study in Diabetic Retinopathy - Interview with Pharmaxis Chief Executive Officer

Pharmaceutical research company Pharmaxis (ASX: PXS) today released a video interview with Chief Executive Officer Gary Phillips discussing the announcement that Boehringer Ingelheim is initiating a Phase 2a study in a second disease indication for the drug it acquired from Pharmaxis in 2015.

The five minute video interview can be accessed via the following link:

https://www.youtube.com/watch?v=OSB0fGkW5Kk

25th Aug 17

Boehringer Ingelheim Initiates Phase IIa Study in NASH - Interview with Pharmaxis Chief Executive Officer

Pharmaceutical research company Pharmaxis (ASX: PXS) today released a video interview with Chief Executive Officer Gary Phillips following the joint announcement with Boehringer Ingelheim that it has initiated a Phase 2a study in the fatty liver disease NASH, triggering the payment of an €18 million (A$27M) milestone to Pharmaxis.

The five minute video interview can be accessed via the following link:

https://www.youtube.com/watch?v=L7ErC89Y_G8